Skip to content
The U.S. Food and Drug Administration (FDA) last week announced approval of an initial treatment for advanced melanoma, the deadliest form of skin cancer. […]
Bristol-Myers Squibb’s new cancer immunotherapy gets FDA approval Read More »
Two new studies show the high effectiveness of COVID-19 vaccines and boosters against three variants of concern (Alpha, Delta, and Omicron), the Centers for
Reports show boosters increase protection against Omicron, decrease risk of death Read More »
Australian regulators last week approved a new malaria treatment for children that includes a single-dose medication and promises a new weapon in defeating the
Australia approves use of tafenoquine to treat malaria in children Read More »
Tuberculosis (TB), an infectious disease, is one of the leading causes of death worldwide. The World Health Organization, which marks World Tuberculosis Day today,
World Tuberculosis Day: Investment needed to tackle rising TB cases Read More »
Pfizer and Moderna are both requesting Food and Drug Administration (FDA) emergency use authorization for a second booster shot of their mRNA vaccines against
Moderna and Pfizer ask FDA to OK more boosters Read More »
The UN Environment Programme (UNEP) has joined the One Health partnership, which includes the Food and Agriculture Organization of the United Nations (FAO), the
The UNEP joined a group addressing One Health challenges Read More »
Heart disease is the leading cause of death in America with about 659,000 people in the United States dying from heart disease each year,
When it comes to heart health, March 24th could save your life Read More »
Black individuals in the United States had a disproportionately higher rate of hospitalization due COVID-19 in January, the Centers for Disease Control and Prevention
CDC: Omicron hospitalization rates higher among Black adults Read More »
While “37 million people in the United States are estimated to have chronic kidney disease (CKD),” most don’t know about it, according to the
National Kidney Month focuses on paths to better care Read More »
Legislation to modernize the clinical drug development paradigm should be patient-centric, effective and inclusive, Biotechnology Innovation Organization (BIO) Chief Scientific Officer Dr. Cartier Esham
BIO’s CSO testifies at congressional hearing on PDUFA riders Read More »
